How many studies have been conducted on Alpha 2 Antiplasmin?

BiohacksAI has indexed 300 PubMed studies on Alpha 2 Antiplasmin, including 7 randomized controlled trials (RCTs). 33% of studies involve human subjects.

What are the main research areas for Alpha 2 Antiplasmin?

The primary research domains for Alpha 2 Antiplasmin are ❤️ Cardiovascular, 🫁 Liver & Detox, 🔬 Oncology. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Alpha 2 Antiplasmin

A member of the serpin superfamily found in plasma that inhibits the lysis of fibrin clots which are induced by plasminogen activator. It is a glycoprotein, molecular weight approximately 70,000 that migrates in the alpha 2 region in immunoelectrophoresis. It is the principal plasmin inactivator in blood, rapidly forming a very stable complex with plasmin.

300+ PubMed studies analyzed · 7 RCTs · Evidence Score: 49.4

Research Domains

Alpha 2 Antiplasmin has been studied across 14 research domains including ❤️ Cardiovascular, 🫁 Liver & Detox, 🔬 Oncology, 😴 Sleep, 🫁 Respiratory. The primary research focus is ❤️ Cardiovascular with 7% of studies addressing this area.

Loading evidence profile...

This evidence profile for Alpha 2 Antiplasmin is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.